These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35631687)

  • 21. An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants.
    Uraki R; Imai M; Ito M; Yamayoshi S; Kiso M; Jounai N; Miyaji K; Iwatsuki-Horimoto K; Takeshita F; Kawaoka Y
    NPJ Vaccines; 2024 Jan; 9(1):4. PubMed ID: 38167505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ferritin-binding and ubiquitination-modified mRNA vaccines induce potent immune responses and protective efficacy against SARS-CoV-2.
    Yu T; Zhang C; Xing J; Zhang T; Xu Z; Di Y; Yang S; Jiang R; Tang J; Zhuang X; Jin N; Tian M
    Int Immunopharmacol; 2024 Mar; 129():111630. PubMed ID: 38320355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circular RNA vaccines against SARS-CoV-2 and emerging variants.
    Qu L; Yi Z; Shen Y; Lin L; Chen F; Xu Y; Wu Z; Tang H; Zhang X; Tian F; Wang C; Xiao X; Dong X; Guo L; Lu S; Yang C; Tang C; Yang Y; Yu W; Wang J; Zhou Y; Huang Q; Yisimayi A; Liu S; Huang W; Cao Y; Wang Y; Zhou Z; Peng X; Wang J; Xie XS; Wei W
    Cell; 2022 May; 185(10):1728-1744.e16. PubMed ID: 35460644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccine.
    Chen Q; Du P; Han Y; Ma X; Zhang R; Rong X; Zhao X; Ma R; Yang H; Zheng A; Huang Q; Yan J; Wang H; Zhao X; Dai L; Gao GF; Wang Q
    Biosaf Health; 2023 Apr; 5(2):89-100. PubMed ID: 37123450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants.
    Mamedov T; Yuksel D; Gurbuzaslan I; Ilgin M; Gulec B; Mammadova G; Ozdarendeli A; Pavel STI; Yetiskin H; Kaplan B; Uygut MA; Hasanova G
    Front Plant Sci; 2023; 14():1202570. PubMed ID: 37600182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The investigation of mRNA vaccines formulated in liposomes administrated in multiple routes against SARS-CoV-2.
    Huang H; Zhang C; Yang S; Xiao W; Zheng Q; Song X
    J Control Release; 2021 Jul; 335():449-456. PubMed ID: 34029632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection.
    Olivera-Ugarte SM; Bolduc M; Laliberté-Gagné MÈ; Blanchette LJ; Garneau C; Fillion M; Savard P; Dubuc I; Flamand L; Farnòs O; Xu X; Kamen A; Gilbert M; Rabezanahary H; Scarrone M; Couture C; Baz M; Leclerc D
    Nanomedicine; 2022 Aug; 44():102584. PubMed ID: 35850421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccine based on folded receptor binding domain-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants.
    Gattinger P; Kratzer B; Tulaeva I; Niespodziana K; Ohradanova-Repic A; Gebetsberger L; Borochova K; Garner-Spitzer E; Trapin D; Hofer G; Keller W; Baumgartner I; Tancevski I; Khaitov M; Karaulov A; Stockinger H; Wiedermann U; Pickl WF; Valenta R
    Allergy; 2022 Aug; 77(8):2431-2445. PubMed ID: 35357709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A fourth dose of Omicron RBD vaccine enhances broad neutralization against SARS-CoV-2 variants including BA.1 and BA.2 in vaccinated mice.
    Zhou B; Song S; Guo H; Zhou X; Fan Q; Liu W; Cheng L; Ge X; Ju B; Zhang Z
    J Med Virol; 2022 Aug; 94(8):3992-3997. PubMed ID: 35474319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A vaccine based on the yeast-expressed receptor-binding domain (RBD) elicits broad immune responses against SARS-CoV-2 variants.
    Liu Y; Zhao D; Wang Y; Chen Z; Yang L; Li W; Gong Y; Gan C; Tang J; Zhang T; Tang D; Dong X; Yang Q; Valencia CA; Dai L; Qi S; Dong B; Chow HY; Li Y
    Front Immunol; 2022; 13():1011484. PubMed ID: 36439096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5-included SARS-CoV-2 variants than homologous vaccination of mRNA vaccine.
    Peng D; Zhao T; Hong W; Fu M; He C; Chen L; Ren W; Lei H; Yang J; Alu A; Ni Y; Liu J; Li J; Wang W; Shen G; Zhao Z; Yang L; Yang J; Wang Z; Tanaka Y; Lu G; Song X; Wei X
    MedComm (2020); 2023 Apr; 4(2):e238. PubMed ID: 36911160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge.
    Wong TY; Russ BP; Lee KS; Miller OA; Kang J; Cooper M; Winters MT; Rodriguez-Aponte SA; Dalvie NC; Johnston RS; Rader NA; Wong ZY; Cyphert HA; Martinez I; Shaligram U; Batwal S; Lothe R; Chandrasekaran R; Nagar G; Rajurkar M; Rao H; Bevere JR; Barbier M; Love JC; Damron FH
    mSphere; 2022 Aug; 7(4):e0024322. PubMed ID: 35968964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation Analysis of Anti-SARS-CoV-2 RBD IgG and Neutralizing Antibody against SARS-CoV-2 Omicron Variants after Vaccination.
    Takheaw N; Liwsrisakun C; Chaiwong W; Laopajon W; Pata S; Inchai J; Duangjit P; Pothirat C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A; Tajarernmuang P; Niyatiwatchanchai N; Trongtrakul K; Kasinrerk W
    Diagnostics (Basel); 2022 May; 12(6):. PubMed ID: 35741126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose.
    Belik M; Liedes O; Vara S; Haveri A; Pöysti S; Kolehmainen P; Maljanen S; Huttunen M; Reinholm A; Lundberg R; Skön M; Österlund P; Melin M; Hänninen A; Hurme A; Ivaska L; Tähtinen PA; Lempainen J; Kakkola L; Jalkanen P; Julkunen I
    Front Immunol; 2023; 14():1099246. PubMed ID: 36756112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant.
    He C; Yang J; Hong W; Chen Z; Peng D; Lei H; Alu A; He X; Bi Z; Jiang X; Jia G; Yang Y; Zhou Y; Yu W; Tang C; Huang Q; Yang M; Li B; Li J; Wang J; Que H; Chen L; Ren W; Wan D; Li J; Wang W; Shen G; Zhao Z; Yang L; Yang J; Wang Z; Su Z; Wei Y; Cen X; Tanaka Y; Song X; Lu S; Peng X; Lu G; Wei X
    Nat Commun; 2022 Sep; 13(1):5459. PubMed ID: 36115859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2.
    Huang Q; Ji K; Tian S; Wang F; Huang B; Tong Z; Tan S; Hao J; Wang Q; Tan W; Gao GF; Yan J
    Nat Commun; 2021 Feb; 12(1):776. PubMed ID: 33536425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral immune response to authentic circulating severe acute respiratory syndrome coronavirus 2 variants elicited by booster vaccination with distinct receptor-binding domain subunits in mice.
    Jiang Y; Zhang H; Yu J; Huang D; Zhai L; Li M; Wang Y; Ren Z; Zou L; Zheng Z; Hu H; Zhang J; Zhang B; Zhao W; Yang X; Li B; Shen C
    J Med Virol; 2022 Sep; 94(9):4533-4538. PubMed ID: 35614018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants.
    Jiang L; Driedonks TAP; Jong WSP; Dhakal S; van den Berg van Saparoea HB; Sitaras I; Zhou R; Caputo C; Littlefield K; Lowman M; Chen M; Lima G; Gololobova O; Smith B; Mahairaki V; Richardson MR; Mulka KR; Lane AP; Klein SL; Pekosz A; Brayton CF; Mankowski JL; Luirink J; Villano JS; Witwer KW
    bioRxiv; 2022 Feb; ():. PubMed ID: 35132418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 Infection.
    Elia U; Rotem S; Bar-Haim E; Ramishetti S; Naidu GS; Gur D; Aftalion M; Israeli M; Bercovich-Kinori A; Alcalay R; Makdasi E; Chitlaru T; Rosenfeld R; Israely T; Melamed S; Abutbul Ionita I; Danino D; Peer D; Cohen O
    Nano Lett; 2021 Jun; 21(11):4774-4779. PubMed ID: 34032435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants.
    Liang Q; Wang Y; Zhang S; Sun J; Sun W; Li J; Liu Y; Li M; Cheng L; Jiang Y; Wang R; Zhang R; Yang Z; Ren Y; Chen P; Gao P; Yan H; Zhang Z; Zhang Q; Shi X; Wang J; Liu W; Wang X; Ying B; Zhao J; Qi H; Zhang L
    iScience; 2022 Apr; 25(4):104043. PubMed ID: 35291264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.